Total Payments
$1.1M
2024 Payments
$806.60
Companies
18
Transactions
183
Medicare Patients
1,733
Medicare Billing
$143,464
Payment Breakdown by Category
Research$1.1M (99.5%)
Food & Beverage$4,272 (0.4%)
Travel$1,324 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.1M | 6 | 99.5% |
| Food and Beverage | $4,272 | 170 | 0.4% |
| Travel and Lodging | $1,324 | 7 | 0.1% |
Payments by Type
Research
$1.1M
6 transactions
General
$5,596
177 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $1.1M | 4 | $0 (2018) |
| Eli Lilly and Company | $10,790 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,441 | 22 | $0 (2024) |
| Novo Nordisk Inc | $1,311 | 50 | $0 (2024) |
| Abbott Laboratories | $826.20 | 37 | $0 (2024) |
| ABBVIE INC. | $802.65 | 32 | $0 (2024) |
| Relievant Medsystems, Inc. | $275.47 | 1 | $0 (2022) |
| Amgen Inc. | $267.06 | 10 | $0 (2021) |
| MannKind Corporation | $124.51 | 1 | $0 (2023) |
| Allergan, Inc. | $105.97 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $806.60 | 32 | Abbott Laboratories ($265.65) |
| 2023 | $4,332 | 26 | Eli Lilly and Company ($3,715) |
| 2022 | $8,005 | 33 | Eli Lilly and Company ($7,075) |
| 2021 | $639.55 | 31 | Novo Nordisk Inc ($150.49) |
| 2020 | $348.79 | 16 | Novo Nordisk Inc ($116.32) |
| 2019 | $541.50 | 12 | Novo Nordisk Inc ($247.83) |
| 2018 | $1.1M | 28 | ACADIA Pharmaceuticals Inc ($1.1M) |
| 2017 | $122.75 | 5 | Amgen Inc. ($103.34) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes Care | ||||||
| 09/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $114.09 | General |
| 09/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes Care | ||||||
| 08/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Diabetes Care | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Diabetes Care | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes Care | ||||||
| 05/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Diabetes Care | ||||||
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Diabetes Care | ||||||
| 04/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-048 | ACADIA Pharmaceuticals Inc | $584,731 | 3 |
| ACP-103-049 | ACADIA Pharmaceuticals Inc | $490,402 | 1 |
| A PHASE 1, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, SINGLE-ASCENDING DOSE STUDY OF LY3844583 IN HEALTHY PARTICIPANTS, AND MULTIPLE-DOSE STUDY OF LY3844583 IN HEALTHY PARTICIPANTS AND PATIENTS WITH ATOPIC DERMATITIS | Eli Lilly and Company | $7,075 | 1 |
| A PHASE 1 MULTICENTER RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND SINGLE-ASCENDING DOSE STUDY OF LY3844583 IN HEALTHY PARTICIPANTS AND MULTIPLE-DOSE STUDY OF LY3844583 IN HEALTHY PARTICIPANTS AND PATIENTS WITH ATOPIC DERMATITIS | Eli Lilly and Company | $3,715 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 513 | 616 | $93,420 | $42,163 |
| 2022 | 9 | 481 | 596 | $85,878 | $40,313 |
| 2021 | 9 | 435 | 559 | $81,373 | $38,804 |
| 2020 | 8 | 304 | 368 | $53,490 | $22,183 |
Total Patients
1,733
Total Services
2,139
Medicare Billing
$143,464
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 149 | $35,015 | $14,410 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $20,750 | $11,650 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 129 | $20,640 | $8,189 | 39.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 90 | 90 | $3,690 | $1,859 | 50.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 83 | 83 | $3,403 | $1,715 | 50.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,680 | $1,511 | 89.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $5,192 | $1,304 | 25.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,400 | $935.76 | 66.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 11 | $1,650 | $590.26 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 135 | $31,725 | $13,051 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $19,000 | $10,928 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 125 | $20,000 | $8,251 | 41.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $2,160 | $1,851 | 85.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 81 | 81 | $3,321 | $1,713 | 51.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 78 | 78 | $3,198 | $1,618 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,700 | $1,126 | 66.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,318 | $1,036 | 31.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 11 | 26 | $1,456 | $738.80 | 50.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 126 | $29,590 | $12,780 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $16,500 | $9,707 | 58.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 130 | $20,800 | $8,960 | 43.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 30 | 30 | $2,400 | $1,958 | 81.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 70 | 70 | $2,870 | $1,489 | 51.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 64 | 64 | $2,624 | $1,361 | 51.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,540 | $1,198 | 33.8% |
About Dr. Esther Yoon, M.D
Dr. Esther Yoon, M.D is a Family Medicine healthcare provider based in Glendale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174725683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esther Yoon, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $806.60 received in 2024. These payments were reported across 183 transactions from 18 companies. The most common payment nature is "" ($1.1M).
As a Medicare-enrolled provider, Yoon has provided services to 1,733 Medicare beneficiaries, totaling 2,139 services with total Medicare billing of $143,464. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Glendale, CA
- Active Since 06/05/2007
- Last Updated 01/28/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174725683
Products in Payments
- NUPLAZID (Drug) $1.1M
- Ozempic (Drug) $419.57
- Tresiba (Drug) $372.83
- FREESTYLE LIBRE 2 (Device) $369.95
- FREESTYLE LIBRE 3 (Device) $290.28
- Intracept (Device) $275.47
- TRELEGY ELLIPTA (Drug) $247.91
- Rybelsus (Drug) $246.66
- UBRELVY (Drug) $242.96
- Creon (Drug) $209.90
- NURTEC ODT (Drug) $133.37
- V-GO (Device) $124.51
- FreeStyle Libre Pro (Device) $124.09
- Victoza (Drug) $116.44
- QULIPTA (Drug) $110.41
- Aimovig (Biological) $108.71
- Prolia (Biological) $103.34
- Vascepa (Drug) $84.21
- LINZESS (Drug) $73.67
- CREON (Drug) $71.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Glendale
Dr. David Han, M.d, M.D
Family Medicine — Payments: $148,437
Family Medicine $148,437
Dr. Narine Arutyounian, M.d, M.D
Family Medicine — Payments: $110,426
Family Medicine $110,426
Dr. Rachel Langland, M.d, M.D
Family Medicine — Payments: $84,212
Family Medicine $84,212
Dr. Arthur Babakhanians, Md, MD
Family Medicine — Payments: $41,750
Family Medicine $41,750
Kecia Smette, Do, DO
Family Medicine — Payments: $40,747
Family Medicine $40,747
Mr. Saro Avakian, M.d, M.D
Family Medicine — Payments: $32,460
Family Medicine $32,460